State v. James Burke Jarreau

563 S.W.3d 477
Court of Appeals of Texas·Decided October 31, 2018·No. 04-15-00313-CR·Published·Cited by 5 cases

Opinion

Fourth Court of Appeals San Antonio, Texas OPINION

No. 04-15-00313-CR

The STATE of Texas, Appellant/Cross-Appellee

v.

James Burke JARREAU, Appellee/Cross-Appellant

From the 216th Judicial District Court, Gillespie County, Texas Trial Court No. 5552 Honorable N. Keith Williams, Judge Presiding

Opinion by: Marialyn Barnard, Justice

Sitting: Karen Angelini, Justice Marialyn Barnard, Justice Luz Elena D. Chapa, Justice

Delivered and Filed: October 31, 2018

MOTION TO DISMISS CROSS-APPEAL GRANTED; CROSS-APPEAL DISMISSED; REVERSED AND REMANDED

Appellant James Burke Jarreau was charged with delivery or offer of delivery of a

dangerous drug, specifically 25B-NBOMe. Jarreau moved to quash the indictment alleging,

among other things, that it failed to allege which of the two statutory definitions of “dangerous

drug” the State intended to rely on, i.e., “device” or “drug.” The trial court granted the motion to

quash on that ground as well as three others. On original submission to this court, we held the trial

court did not err in granting the motion to quash because the State was required to specify which

definition of “dangerous drug” it intended to rely upon at trial. State v. Jarreau, No. 04-15-00313- 04-15-00313-CR

CR, 2016 WL 3440481, at *4–*5 (Tex. App.—San Antonio June 22, 2016) (mem. op., not

designated for publication), rev’d, 512 S.W.3d 352 (Tex. Crim. App. 2017). We held that because

the indictment “did not ‘elect[] among the alternate statutory manner or means’ of committing the

offense of deliver or offer to deliver a dangerous drug — by device or by drug that is unsafe for

self-medication” — it failed to provide sufficient notice to inform Jarreau of the specific acts for

which he was charged. Id. at *6–*7. The State filed a petition for discretionary review. The Texas

Court of Criminal Appeals granted the State’s petition and reversed our judgment, holding “[t]he

nature of 25B-NBOMe as a device or drug is not a manner or means of delivery of a dangerous

drug and does not describe, concern, involve or go to the act of delivery; thus, the charging

instrument did not have to specify ‘device’ or ‘drug.’” Jarreau, 512 S.W.3d at 356. The court

remanded the matter back to this court “for consideration of the State’s remaining points of error.”

Id. at 356–57. On remand, we reverse the trial court’s order granting the motion to quash and

remand this matter to the trial court for further proceedings consistent with our opinion. In

addition, we grant the State’s motion to dismiss Jarreau’s cross-appeal and order the cross-appeal

dismissed.

BACKGROUND

The State indicted Jarreau for delivery or offer of delivery of a dangerous drug. The

indictment alleged Jarreau “did then and there intentionally or knowingly deliver or offer to deliver

to [M.J.] a dangerous drug, specifically 25B-NBOMe.” 1 Jarreau filed two motions to quash the

indictment. In thE first motion, he alleged the indictment fails to provide adequate notice or define

the term “dangerous drug.” Approximately a month later, Jarreau filed a second motion to quash.

1 Effective September 1, 2015, the Legislature added 25B-NBOMe to penalty group 1-A in the Texas Controlled Substances Act. Act of May 22, 2015, 84th Leg., R.S., ch. 64, § 2, 2015 Tex. Gen. Laws __ (current version at TEX. HEALTH & SAFETY CODE ANN. § 481.1021(a)(2)(B)).

-2- 04-15-00313-CR

In his second motion, which is the motion ruled upon by the trial court, Jarreau complained the

indictment is defective because it: (1) fails to allege why 25B-NBOMe is a dangerous drug under

section 483.001(a) of the Texas Health and Safety Code (“the Code”); (2) fails to state an offense

because 25B-NBOMe did not bear and was not required to bear the legends required by

subsections (A) and (B) of section 483.001(2) of the Code; (3) fails to allege which of the various

statutory definitions of “dangerous drug” under section 483.001(2) of the Code — drug or device

— the State intends to rely on in its prosecution, thereby failing to provide adequate notice; (4)

fails to allege which of the various statutory definitions of “dangerous drug” under section

481.002(16) of the Code the State intends to rely on in its prosecution, thereby failing to provide

adequate notice; (5) alleges a delivery or offer to deliver, but does not state whether the delivery

in question was by actual or constructive transfer; (6) alleges Jarreau delivered or offered to deliver

a dangerous drug, but does not allege the manner and means of the purported delivery or offer to

deliver; (7) the statute underlying the indictment — section 483.042(a) of the Code, which makes

delivery or an offer of delivery of a dangerous drug a criminal offense — is unconstitutionally

vague, facially and as applied; and (8) alleges Jarreau delivered or offered to deliver a dangerous

drug, but does not allege he knew the thing delivered was a dangerous drug or any kind of

contraband.

After a hearing, the trial court took the matter under advisement. A subsequent hearing

was scheduled. On the day of the hearing, but before the trial court ruled on the motion to quash,

the State filed a motion to amend the indictment, seeking to include more specificity regarding the

manner and means of delivery. At the hearing, the trial court verbally denied the State’s motion

to amend and thereafter, granted Jarreau’s second motion to quash. At the State’s request, the trial

court stated on the record it was granting Jarreau’s motion because the indictment failed to allege:

-3- 04-15-00313-CR

• why 25B-NBOMe is a dangerous drug under section 483.001(a) of the Code;

• which of the various statutory definitions of “dangerous drug” the State intended to rely on;

• whether the delivery in question was by actual or constructive transfer; and

• the manner and means of the purported delivery or offer to deliver.

Thereafter, the trial court signed the order granting Jarreau’s motion to quash. The State

filed a notice of appeal. After the State filed its notice of appeal, Jarreau filed a cross-notice of

appeal, seeking to affirm the trial court’s order on the grounds the trial court denied, expressly or

by implication. In response, the State filed a motion to strike Jarreau’s cross-appellant’s brief and

the points therein — which we interpreted as a motion to dismiss for want of jurisdiction. Jarreau

filed a response. After reviewing the motion and the response, we ordered the motion and response

carried with the appeal.

As set out above, we held the trial court did not err in granting the motion to quash because

the State was required to specify which definition of “dangerous drug” it intended to rely upon at

trial, thereby failing to provide Jarreau with sufficient notice of the specific acts with which he was

charged. Jarreau, 2016 WL 3440481, at *4–*7. Based on our decision, we denied as moot the

State’s motion to dismiss Jarreau’s cross-appeal. However, the court of criminal appeals reversed

our judgment, holding that because the type of drug involved is not a manner or means of delivery

of a dangerous drug and does not describe, concern, involve, or go to the act of delivery, the State

is not required to specify the specific type of drug involved. Jarreau, 512 S.W.3d at 356. The

court remanded the matter back to this court. Id. at 356–57.

On remand, we permitted the parties to file supplemental briefs. In addition to filing a

Free access — add to your briefcase to read the full text and ask questions with AI

State v. James Burke Jarreau, 563 S.W.3d 477 (Tex. Ct. App. 2018).

563 S.W.3d 477 (State v. James Burke Jarreau) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Vandamme Jeanty v. the State of Texas
Court of Appeals of Texas, 2023
Victor Anthony Charles v. the State of Texas
Court of Appeals of Texas, 2022
Ex Parte James Burke Jarreau
Court of Appeals of Texas, 2020
Bonnie Allen Thomas v. State
Court of Appeals of Texas, 2019